Catalyst Wire Dossier Catalyst Wire Dossier

Avacincaptad pegol

avacincaptad pegol · Astellas Pharma Global Development, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Avacincaptad pegol, covering 2026-04-14 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: Avacincaptad Pegol Open-Label Extension for Patients With Geographic Atrophy [Phase 3]

See pricing